The Florence Wormald Heart & Vascular Institute at St. Elizabeth Healthcare has achieved a significant breakthrough in cardiac treatment by introducing the Aurora EV-ICD™ system. This innovative device, the first of its kind in Kentucky and the Greater Cincinnati area, targets fast or irregular heartbeats to prevent sudden cardiac arrest.

Under the guidance of Dr. J. Christian Hays, MD, the Cardiac Electrophysiology team at St. Elizabeth Healthcare is addressing the critical issue of arrhythmias, which disrupt the heart's normal rhythm and can lead to severe complications.

Implantable cardioverter-defibrillators (ICDs) have long been used to manage arrhythmias by monitoring heart rhythms and delivering corrective electrical signals. However, the Aurora EV-ICD system sets itself apart by placing leads outside the heart and veins. Implanted below the left armpit with leads positioned under the breastbone, it continuously monitors heart activity and intervenes when irregularities are detected.

When the Aurora EV-ICD detects an irregular heartbeat or tachycardia, it delivers electrical signals through the leads to restore a normal heart rate. In cases of persistent fast heartbeats, the device can administer an electric shock to reset the heart rhythm.

Additionally, the Aurora EV-ICD offers features like Antitachycardial pacing (ATP) and post-shock pacing, enhancing its effectiveness in managing various cardiac conditions.

This groundbreaking device provides a promising treatment option for individuals diagnosed with arrhythmias, heart failure, heart attacks, or previous sudden cardiac arrest events.

The introduction of the Aurora EV-ICD at St. Elizabeth Healthcare reflects a commitment to advancing cardiovascular care and improving patient outcomes in the Kentucky and Greater Cincinnati region.

Source: prnewswire.com

 

 

Report Abuse